Clinical Trials on Muscle-Invasive Bladder Cancer (MIBC)

Total 2323 results

Fujian Medical University Union Hospital
BeiGene

Recruiting

Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC (HARBOR)

Muscle Invasive Bladder Cancer (MIBC)

China
Harbin Medical University
Jilin Provincial Tumor Hospital; First Hospital of China Medical University; Tianjin... and other collaborators

Not yet recruiting

Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer

Muscle-Invasive Bladder Cancer (MIBC)
chenxu

Not yet recruiting

Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC

Muscle Invasive Bladder Cancer (MIBC)

China
Qilu Hospital of Shandong University

Not yet recruiting

Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment

Muscle Invasive Bladder Cancer (MIBC)
Assiut University

Not yet recruiting

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Bladder Carcinoma | Urothelial Bladder Carcinoma | Non-Muscle-Invasive Bladder Cancer (NMIBC) | Muscle-Invasive Bladder Cancer (MIBC)

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe